A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.

Clinical trial NCT06953739 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06953739
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

NK-T-Cell Lymphoma, Extranodal

Start date: 2025-05-01
Primary completion: 2027-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.